Xoma Corporation (XOMA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2200 POWELL STREET EMERYVILLE, CA 94608

Xoma Corporation develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer, and infectious diseases. Programs include collaborations with Genentech, Millennium Pharmaceuticals and AphtonCorp.

Data as of 2021-05-08 10:29:59 -0400
Market Cap357.81 Million Shares Outstanding11.27 Million Avg 30-day Volume33.653 Thousand
P/E Ratio40.69255 Dividend Yield EPS0.764
Price/Sales12.18 Debt to Equity1.45 EBITDA12.438 Million
Price to Book Value4.14 Forward PE-114.76 Enterprise Value294.44 Million
Total Cash84.222 Million Current Debt12.302 Million Gross Profit29.385 Million
BETA1.31219 52-week High/Low46.32 / 15.48 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from XOMA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 61 55 10.91% 15 (0.9%) 14 (0.87%) 7.14%
13F shares: 6.437 Million 6.318 Million 1.89% 4.998 Million 5.03 Million -0.63%
% Ownership 58.4049 57.3215 1.89% 45.3485 45.6361 -0.63%
New Positions: 11 5 120.0% 4 2 100.0%
Increased Positions 18 12 50.0% 5 3 66.67%
Closed Positions 6 7 -14.29% 3 3 0.0%
Reduced Positions 11 18 -38.89% 2 4 -50.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding XOMA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XOMA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

651.7 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

5.7 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NEAL JAMES R CEO

41,815 2021-04-09 5

BURNS THOMAS M. SVP, FINANCE & CFO

13,458 2021-04-09 5

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • Director
  • 10% Owner
  • SEE REMARKS SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
476,657 2021-03-31 2

VAN NESS W DENMAN

15,644 2021-03-15 2

HERNDAY NATASHA

4,000 2020-12-15 3

PERRY MATTHEW D

  • Director
  • SEE EXPLANATION OF RESPONSES
211,799 2020-12-11 2

WYSZOMIERSKI JACK L

0 2020-05-20 1

LIMBER JOSEPH M

0 2020-05-20 1

KOSACZ BARBARA

0 2020-05-20 1

BVF GP HOLDINGS LLC

BVF I GP LLC

BVF II GP LLC

  • 10% Owner
2,250,990 2020-03-13 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
1,335,192 2019-12-18 6

DATTA DEEPSHIKHA CHIEF BUSINESS OFFICER

  • Officer
0 2019-02-13 0

VARIAN JOHN

  • Director
5,995 2017-05-16 0

HUTT PETER BARTON

  • Director
0 2017-02-10 0

WALBERT TIMOTHY P

  • Director
0 2017-02-10 0

SCANNON PATRICK J MD PHD EXEC. VP & CSO

  • Officer
  • EXEC. VP & CSO
10,146 2016-12-21 0

RUBIN PAUL D SR. VP CLINICAL DEV. & CMO

  • Officer
340,023 2016-03-18 0

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2015-07-22 0

BOWES WILLIAM K JR

  • Director
80,339 2015-05-28 0

KURLAND FRED CFO & VP FINANCE

  • Officer
102,852 2015-04-06 0

KLEIN THOMAS CHIEF COMMERCIAL OFFICER

  • Officer
190,340 2015-03-18 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER BROS ADVISORS LLC

BAKER FELIX

BAKER JULIAN

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

  • Director
  • 10% Owner
20,350,181 2013-05-23 0

NEU KELVIN

  • Director
16,800 2012-07-19 0

667, L.P.

  • Director
1,585,591 2012-07-19 0

14159, L.P.

  • Director
360,231 2012-07-19 0

BAKER BROTHERS LIFE SCIENCES LP

  • Director
13,606,093 2012-07-19 0

BAKER BROS ADVISORS LLC

  • 10% Owner
0 2012-04-12 0

14159 CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
360,231 2012-03-06 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
13,606,093 2012-03-06 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
1,585,591 2012-03-06 0

MARGOLIN CHRISTOPHER J VP, GENERAL COUNSEL & SEC'Y

  • Officer
11,377 2011-12-31 0

ENGLE STEVEN B CHAIRMAN, CEO & PRESIDENT

  • Officer
  • Director
0 2011-01-07 0

FISHER CHARLES J JR

  • Director
0 2011-01-07 0

ZENNER PATRICK J

  • Director
No longer subject to file 2010-07-22 0

ANDRESS JAMES G

  • Director
0 2008-02-21 0

BOYLE J DAVID II VP, FINANCE, AND CFO

  • Officer
0 2008-02-21 0

CASTELLO JOHN L PRESIDENT, CEO AND

  • Officer
  • Director
192,540 2007-12-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NEAL JAMES R CEO by spouse

2021-04-13 16:30:19 -0400 2021-04-09 A 8,000 $25.00 a 8,000 indirect 1.3387 -0.4819 1.3387 2 -5.1138 5

BURNS THOMAS M. SVP, FINANCE & CFO

2021-04-13 16:30:17 -0400 2021-04-09 A 1,000 $25.00 a 1,000 direct 1.3387 -0.4819 1.3387 2 -5.1138 5

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP - > 10% Owner

BVF II GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2021-04-02 17:19:46 -0400 2021-03-31 S 205,807 $38.36 d 1,544,897 direct -1.9799 -4.812 0.0 1 -4.812 6

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS see footnote

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner see footnote

BVF I GP LLC - > 10% Owner see footnote

BIOTECHNOLOGY VALUE FUND II LP - > 10% Owner see footnote

BVF II GP LLC - > 10% Owner see footnote

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES see footnote

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES see footnote

BVF GP HOLDINGS LLC - > 10% Owner see footnote

BVF INC/IL - > 10% Owner see footnote

LAMPERT MARK N - > 10% Owner see footnote

2021-04-02 17:19:46 -0400 2021-03-31 S 81,903 $38.36 d 149,975 indirect -1.9799 -4.812 0.0 1 -4.812 6

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP - > 10% Owner

BVF II GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2021-04-02 17:19:46 -0400 2021-03-31 S 279,740 $38.36 d 1,760,384 direct -1.9799 -4.812 0.0 1 -4.812 6

BVF PARTNERS L P/IL - Director - > 10% Owner SEE REMARKS

BIOTECHNOLOGY VALUE FUND L P - > 10% Owner

BVF I GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE FUND II LP - > 10% Owner

BVF II GP LLC - > 10% Owner

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF GP HOLDINGS LLC - > 10% Owner

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2021-04-02 17:19:46 -0400 2021-03-31 S 84,250 $38.36 d 75,287 direct -1.9799 -4.812 0.0 1 -4.812 6

VAN NESS W DENMAN

2021-03-16 16:30:28 -0400 2021-03-15 M 2,366 $19.40 a 12,310 direct -4.2674 -12.3393 -4.91 4.91 11 -14.6272 7

VAN NESS W DENMAN

2021-03-16 16:30:28 -0400 2021-03-15 M 2,366 d 0 direct

VAN NESS W DENMAN

2021-03-16 16:30:28 -0400 2021-03-15 M 3,333 $4.03 a 15,643 direct -4.2674 -12.3393 -4.91 4.91 11 -14.6272 7

VAN NESS W DENMAN

2021-03-16 16:30:28 -0400 2021-03-15 M 3,333 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
XOMA CORP XOMA 2021-05-10 22:15:04 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 21:45:02 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 21:15:02 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 20:45:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 20:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 19:45:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 19:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 18:45:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 18:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 17:45:02 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 17:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 16:45:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 16:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 15:45:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 15:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 14:45:04 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 14:15:04 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 13:45:04 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 13:15:03 UTC -1.4413 1.4913 45000
XOMA CORP XOMA 2021-05-10 12:45:02 UTC -1.4413 1.4913 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments